Audio By Carbonatix
A vaccine against coronavirus appears to have provided protection against the disease Covid-19 in six rhesus macaque monkeys.
It gives early hope for the vaccine, which is now undergoing human clinical trials.
There is no guarantee this result will translate to people, though.
The animals who had been given the vaccine, and were then exposed to SARS-CoV-2, had less of the virus in their lungs and airways.
That's compared with the control group of monkeys which was not given the vaccine.
The trial took place in the US, involving researchers from the US government's National Institutes of Health (NIH) and from the University of Oxford.
The vaccine appeared to protect the animals against developing pneumonia.
Rhesus macaques have similar immune systems to humans.
Promisingly, they also didn't develop "immune-enhanced disease" - which BBC medical correspondent Fergus Walsh describes as a "theoretical risk". That's when the vaccine triggers a worse response to a disease.
How close to developing a vaccine are we?
This response was seen in some early animal vaccine trials against SARS - another coronavirus - and proved a stumbling block in developing a vaccine for that disease.
The study hasn't yet been reviewed by other scientists and formally published, but Prof Stephen Evans at the London School of Hygiene and Tropical Medicine, described it as "high quality" and "very encouraging".
Meanwhile, trials in the UK on more than 1,000 human volunteers are currently taking place through the University of Oxford.
There are more than 100 experimental coronavirus vaccines currently being developed.
Dr Penny Ward, a visiting professor in pharmaceutical medicine at King's College London, said it was "helpful" to see that the vaccine didn't cause a worse disease response in these monkeys, and that they didn't develop pneumonia after being vaccinated.
The vaccine is based on a small part of the virus's distinctive "spike". The idea is that by getting the body to recognise a unique part of the virus, when it is exposed to the whole thing it will know how to react, and produce the right antibodies to fight it off.
That did seem to be happening to the vaccinated macaques, which produced antibodies capable of fighting the virus.
Latest Stories
-
The African Union’s expanding footprint in strengthening cross-border tourism and trade unity in Africa
43 seconds -
Today’s Front pages: Tuesday, May 26, 2026
3 minutes -
Netanyahu vows to ‘increase the blows’ against Hezbollah as Israel intensifies strikes in LebanonÂ
12 minutes -
US strikes Iranian missile sites and boats near Strait of Hormuz amid peace talksÂ
19 minutes -
Why it’s time to change Ghana’s cocoa law
23 minutes -
Adamus Resources defends reputation amid renewed public scrutiny
27 minutes -
GN Savings and Loans could resume operations before end of 2026 — Dr Kweku Nduom
53 minutes -
Telecel CEO speaks on closing Africa’s gender gap in technology at Rwandan summit
58 minutes -
Analysis: Why the cedi is depreciating
2 hours -
What are they hiding? – Tech consultant questions rush for 15 digital bills
2 hours -
To nationalise or transform? Joy Business hosts roundtable on Ghana’s extractive future
2 hours -
This is not how modern innovation ecosystems are built – Tech analyst warns over NITA Bill
2 hours -
A web developer could become a criminal – NITA Bill sparks fear among young innovators
2 hours -
Mercy Johnson faces backlash over $18.24 menstrual kit
3 hours -
EU plans to fine Google high triple-digit million euro sum, Handelsblatt reports
3 hours